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Introduction. Myocardial infarction with non-obstructive coronary arteries (MINOCA) in 
contemporary practice involves a large amount of causes and the same number of therapies. 
MINOCA should be considered as a working diagnosis in order to determine physicians find 
the specific causes of its appearance, clarify the underlying individual mechanisms and achieve 
patient-specific treatments, although the mechanism of the myocardial damage in these patients 
remains unclear.  
Aim of the study. This review aims to better understanding the clinical diagnosis of MINOCA  
Materials and methods. The article is based on international publication data and on-line 
materials.  
Results. Myocardial infarction without obstructive coronary artery disease (MINOCA) is a 
syndrome defined by the presence of the universal acute myocardial infarction (AMI) criteria 
among with normal or near normal coronary arteries and no clinically overt specific cause for 
the acute presentation. As different clinical studies have reported a prevalence with a range 
between 4 - 25% of AMI cases, physicians have been regularly confronting with many 
questions on its management. The demographic and clinical characteristics of MINOCA are 
different from patients with AMI, being more common in younger and in women, having a 
lower prevalence of traditional cardiovascular disease risk factors. Studies made pointed a 
different profile with previous history of depression, emotional stress, inflammatory conditions 
and malignancy. The diagnosis of MINOCA should exclude first other causes for elevated 
troponin, overlooked obstructive coronary disease, nonischemic causes for myocardial injury, 
including Takotsubo syndrome. There are disparate aetiologies causing MINOCA, including: 
coronary disorders (coronary plaque disruption, coronary dissection, coronary spasm, coronary 
thrombus/embolus, microvascular dysfunction); myocardial disorders; non-cardiac disorders 
(e.g.pulmonary embolism). Failure to identify the underlying cause may result in inappropriate 
therapy in these patients. As the plaque disruption, spontaneous coronary artery dissection are 
common in MINOCA, it is recommended to use optical coherence tomography or intravascular 
ultrasound imaging to confirm it. Coronary vasospasm and microvascular dysfunction are other 
frequent findings in MINOCA patients undergoing provocative testing with acetylcholine – the 
gold standard technique. Multiple diagnostic pathways have been proposed to evaluate patients 
with MINOCA, considering as priority cardiac magnetic resonance imaging. Rational 
treatment fallows from etiologic diagnosis, since same therapy will not be appropriate for all 
MINOCA patients. The outcome of MINOCA depends on the underlying cause, but its overall 
prognosis is serious with a 1 year mortality about 3,5%.  
Conclusions. MINOCA is a distinct clinical diagnosis with different pathophysiological 
causes. It is essential that healthcare professionals become familiar with it, use proper 
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diagnostic criteria, additional investigation techniques and determine target therapies for each 
patient, in order to improve their clinical outcome.  
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Background. Heart failure (HF) is the final common pathway of many cardiovascular diseases. 
It imposes significant socio-economic and health care burden to both patients and healthcare 
systems. Although the most common cause of HF is ischemic heart diseases, other less 
common causes such as hyperthyroidism (thyrotoxicosis), severe anemia, arrhythmia should 
also be considered during diagnosis to improve overall clinical management of HF.   
Case report. The 42-year-old man was admitted to cardiology department with mixed 
(inspiratory and expiratory) dyspnea at moderate effort, palpitations, fatigue, the loss in weight 
of about 15 kg during 9-10 months. Anamnesis: general condition worsened the last 2 months 
when appeared generalized edema and mixed dyspnea. During this time did not address to 
doctor, any treatment has not received. Physical examination revealed swelling in the legs, 
ankles, ascites, an irregular pulse, at a rate of 130 beats/min, BP- 110/70mmHg. On ECG - 
atrial fibrillation with rate - 120-57 b/min, electric axis of heart is normal. Signs of left 
ventricular hypertrophy. The chest X-ray -pulmonary congestion, bilateral pleural effusion. 
The abdominal X-ray – fluid levels with air on the left. On TTE- thickening of the walls of the 
aorta and valve apparatus. Dilatation of all heart chambers, significant dilatation of the right 
atrium and right ventricle, and moderate dilatation of the left atrium and the left ventricle. 
Contractile function of the left ventricular myocardium is moderately reduced. Ejection 
fraction = 42%. The second degree mitral regurgitation and third-fourth -degree tricuspid 
regurgitation. Moderate pulmonary arterial hypertension (PASP= 52mmHg). Sheets of the 
pericardium are thickened. Fluid in the pleural cavity up to 11 millimeters in the region of the 
right atrium. Bilateral pleurisy - inhomogeneous fluid with floating elements on the left - about 
1,000 milliliters, to the right - about 800 milliliters. Сytological analysis of fluid from pleural 
cavity pointed to the inflammatory etiology of the effusion. On the ultrasound examination of 
the thyroid gland – fourth –degree hyperplasia, multiple diffuse changes.On the ultrasound 
examination of abdominal cavity - ascites, bilateral pleuritic, diffuse changes in the 
parenchyma of the liver. The glycemic profile -7-00: 4.7 mmol/l, 13-00: 6.3 mmol/l, 17-00: 
10.6 mmol/l, glycated hemoglobin - 5,6%. Analysis of thyroid hormones- free 
Triiodothyronine – 17,22 Pmol/l, free Thyroxine – 79,52 Pmol/l. TSH – ‹ 0, 05 uIU/ml; anti 
TPO- 144 IU/ml. Tumor marker CA 19-9 - <3.0 U/ml. During hospitalization was consulted 
by endocrinologist, surgeon. After 11 days of complex treatment with diuretics, anticoagulants, 
beta-adrenoblockers, antithyroid drugs, cardiac glycosides, corticosteroids, histamine-2-
receptor blockers - the general condition improved: dyspnea and general swelling disappeared, 
general weakness was reduced.   
